22nd Century Group, the biotech company that entered the cannabis space in 2014 with ambitions to monetize cannabis genetics, is abandoning the effort. In 2018, they doubled down on the emerging hemp sector, seeing opportunity in bioinformatics and gene editing. The company is now shedding its cannabis operations, GVB Pharma, selling to Nevada-based Specialty Acquisition Corporation for $2.25 million.
…
12.24.2024
Animal fats, oils markets quiet amid Christmas holiday
The US animal fats and oils markets remained steady on Tuesday December 24, amid limited trading due to the Christmas holidays.
Market sources expected activity to remain subdued...
12.24.2024
US November broiler, turkey slaughter down year on year
US animal protein prices were steady on Tuesday December 24, with limited volumes reported to have been traded. With the proximity of the end-of-year holidays, most market participants are...
12.24.2024
US weekly soybean, wheat export inspections rise, corn falls
Weekly export inspections
Export inspections of US grains showed a decline for corn but an increase for soybean and wheat in the week to December 19, according to data...